AKTX

Akari Therapeutics
AKTX

18 hedge funds and large institutions have $27.5M invested in Akari Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4K

Top Sellers

1
-$197K
2
-$88.7K
3
-$32.7K
4
ACH
ArrowMark Colorado Holdings
Colorado
-$7K
5
TRCT
Tower Research Capital (TRC)
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$8.1M
2
$3.72M
3
$3.5M
4
$3.18M
5
$2.6M
6
$1.45M
7
$1.39M
8
$1.11M
9
$985K
10
$714K
11
$328K
12
$164K
13
$152K
14
$120K
15
$4K
16
$2K
17
–
18
–
19
–